Literature DB >> 19553820

Environmental factors promoting bladder cancer.

Yoshihiko Hirao1, Wun-Jae Kim, Kiyohide Fujimoto.   

Abstract

PURPOSE OF REVIEW: To understand the molecular mechanisms of bladder carcinogenesis in relation to environmental carcinogens in order to provide a given population with a preventive value of bladder cancer. RECENT
FINDINGS: Cigarette smoking, aromatic amines contained in dyes, chronic inflammation due to infection such as schistosomiasis, anticancer drugs, drug abuse of analgesic, and radiation are considered as well known risk factors of bladder cancer. Several environmental factors are supposed to be involved in carcinogenesis, cancer progression, and patient's prognosis in bladder cancer. On the basis of the results of recent genetic studies in relation to bladder carcinogenesis, several genetic polymorphisms of detoxification or DNA repair such as N-acetyltransferase 2, glutathione S-transferases, and human 8-oxoguanine DNA glycosylase 1 give us important information in relation to environmental risk factors and ethnic differences for predicting the prognosis of patients with bladder cancer.
SUMMARY: Prevention of environmental carcinogens is important from the viewpoint of the social and clinical problems since elucidation of the correlation between epidemiologic and genetic phenomenon enable us to improve the life expectancy and quality of life of bladder cancer patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19553820     DOI: 10.1097/MOU.0b013e32832eb4ef

Source DB:  PubMed          Journal:  Curr Opin Urol        ISSN: 0963-0643            Impact factor:   2.309


  17 in total

1.  N-acetyltransferase 2 polymorphisms, tobacco smoking, and breast cancer risk in the breast and prostate cancer cohort consortium.

Authors:  David G Cox; Lucie Dostal; David J Hunter; Loïc Le Marchand; Robert Hoover; Regina G Ziegler; Michael J Thun
Journal:  Am J Epidemiol       Date:  2011-11-10       Impact factor: 4.897

2.  Risk factors for bladder cancer: challenges of conducting a literature search using PubMed.

Authors:  Ashish Joshi; Elicia Preslan
Journal:  Perspect Health Inf Manag       Date:  2011-04-01

3.  Correlation of IL-31 gene polymorphisms with susceptibility and clinical recurrence of bladder cancer.

Authors:  Qin Li; Tielong Tang; Peng Zhang; Chenlu Liu; Yan Pu; Yan Zhang; Huizi Song; Yanyun Wang; Yaping Song; Min Su; Bin Zhou; Lin Zhang
Journal:  Fam Cancer       Date:  2018-10       Impact factor: 2.375

4.  Impact of smoking and smoking cessation on oncologic outcomes in primary non-muscle-invasive bladder cancer.

Authors:  Michael Rink; Helena Furberg; Emily C Zabor; Evanguelos Xylinas; Marko Babjuk; Armin Pycha; Yair Lotan; Pierre I Karakiewicz; Giacomo Novara; Brian D Robinson; Francesco Montorsi; Felix K Chun; Douglas S Scherr; Shahrokh F Shariat
Journal:  Eur Urol       Date:  2012-08-21       Impact factor: 20.096

5.  Multivariate analysis of the prognostic significance of resection weight after transurethral resection of bladder tumor for non-muscle-invasive bladder cancer.

Authors:  Dae Hyeon Kwon; Phil Hyun Song; Hyun Tae Kim
Journal:  Korean J Urol       Date:  2012-07-19

6.  Spatio-temporal patterns of bladder cancer incidence in Utah (1973-2004) and their association with the presence of toxic release inventory sites.

Authors:  Léa Fortunato; Juan José Abellan; Linda Beale; Sam LeFevre; Sylvia Richardson
Journal:  Int J Health Geogr       Date:  2011-02-28       Impact factor: 3.918

7.  GSTM1 tissue genotype as a recurrence predictor in non-muscle invasive bladder cancer.

Authors:  Yun-Sok Ha; Chunri Yan; Pildu Jeong; Won Tae Kim; Seok-Joong Yun; Isaac Yi Kim; Sung-Kwon Moon; Wun-Jae Kim
Journal:  J Korean Med Sci       Date:  2011-01-24       Impact factor: 2.153

8.  Clinical significance of subepithelial growth patterns in non-muscle invasive bladder cancer.

Authors:  Makito Miyake; Shuya Hirao; Hisakazu Mibu; Masahiro Tanaka; Kenji Takashima; Keiji Shimada; Kazuya Hirao
Journal:  BMC Urol       Date:  2011-08-05       Impact factor: 2.264

9.  Origins of injection-site sarcomas in cats: the possible role of chronic inflammation-a review.

Authors:  Kevin N Woodward
Journal:  ISRN Vet Sci       Date:  2011-04-12

10.  What can rheumatologists learn from translational cancer therapy?

Authors:  Jonathan P Sherlock; Andrew D Filer; John D Isaacs; Christopher D Buckley
Journal:  Arthritis Res Ther       Date:  2013       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.